13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001425738
申报总市值
US$14.9亿
US$14.9亿
62 檔
35.6%
根据最新整理的 13F 季度数据集，Redmile Group, LLC 于 Q4 2024 结束时的管理资产规模为 US$14.9亿。该机构在本季度申报了 62 档美股持仓，呈现出该时期的主要投资地图。
在 Q4 2024，Redmile Group, LLC 展现出较为审慎的避险与获利了结姿态。本季共减仓 40 个仓位并完全清仓 4 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Redmile Group, LLC 的前 5 大核心持股（包含 SRRK, KRYS, NRIX 等）合计占整体申报市值的 35.6%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 13.70% | -13.59% | -13.15% | |
| 2 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 8.22% | +4.25% | -7.04% | |
| 3 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 5.50% | -1.30% | -2.06% | |
| 4 | ZYME | Zymeworks Inc | 股票-其他 | 4.94% | +0.04% | -5.12% | |
| 5 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 4.63% | — | -14.45% | |
| 6 | REPL | Replimune Group Inc | 股票-其他 | 4.14% | — | +2.60% | |
| 7 | IMNM | Immunome Inc | 股票-其他 | 3.57% | -1.06% | -1.26% | |
| 8 | STOK | Stoke Therapeutics Inc | 股票-其他 | 3.53% | -0.31% | -2.54% | |
| 9 | LIVN | LivaNova PLC | 股票-其他 | 3.37% | +0.05% | +19.26% | |
| 10 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 3.09% | — | -21.02% | |
| 11 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 2.66% | — | -9.45% | |
| 12 | BEAM | Beam Therapeutics Inc | 股票-其他 | 2.64% | +0.73% | -5.12% | |
| 13 | RGNX | Regenxbio Inc | 股票-其他 | 2.58% | +1.09% | -2.01% | |
| 14 | AKRO | Akero Therapeutics Inc | 股票-其他 | 2.39% | — | -10.97% | |
| 15 | BHVN | Biohaven Ltd. | 股票-其他 | 2.35% | — | -12.54% | |
| 16 | ANNX | Annexon Inc | 股票-其他 | 2.25% | -0.79% | -1.97% | |
| 17 | ✓ | Adc Therapeutics SA | 股票-其他 | 2.17% | -3.01% | -0.02% | |
| 18 | NGNE | Neurogene Inc | 股票-其他 | 2.10% | +1.03% | +36.86% | |
| 19 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.95% | — | -5.50% | |
| 20 | COGT | Cogent Biosciences Inc | 股票-其他 | 1.93% | -0.44% | -20.73% | |
| 21 | ABSI | Absci CORP | 股票-其他 | 1.51% | +3.60% | — | |
| 22 | FATE | Fate Therapeutics Inc | 股票-其他 | 1.48% | +1.31% | -2.25% | |
| 23 | 1K0 | Igm Biosciences Inc | 股票-其他 | 1.26% | — | -3.92% | |
| 24 | ETNBGBP | 89bio Inc | 股票-其他 | 1.18% | — | +38.05% | |
| 25 | SLN | Silence Therapeutics Plc-adr | 股票-其他 | 1.15% | +0.84% | +26.33% | |
| 26 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 1.11% | +0.45% | -9.08% | |
| 27 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.08% | +0.53% | -6.30% | |
| 28 | ✓ | Establishment Labs Holdings In | 股票-其他 | 1.03% | +0.12% | +22.29% | |
| 29 | IMVT | Immunovant Inc | 股票-其他 | 0.99% | — | -10.96% | |
| 30 | CBLL | Ceribell Inc | 股票-其他 | 0.79% | +0.04% | — | |
| 31 | SYK | Stryker CORP | 股票-医疗保健 | 0.77% | — | -6.31% | |
| 32 | ✓ | Rapt Therapeutics Inc | 股票-其他 | 0.71% | — | +1183.43% | |
| 33 | BNTX | Biontech Se-adr | 股票-其他 | 0.66% | — | -45.96% | |
| 34 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 0.62% | — | -36.54% | |
| 35 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.61% | — | — | |
| 36 | NUVB | Nuvation Bio Inc | 股票-其他 | 0.56% | +0.26% | — | |
| 37 | ARDX | Ardelyx Inc | 股票-其他 | 0.56% | -0.07% | -5.09% | |
| 38 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.56% | — | — | |
| 39 | ✓ | Verve Therapeutics Inc | 股票-其他 | 0.52% | — | -4.71% | |
| 40 | STTK | Shattuck Labs Inc | 股票-其他 | 0.47% | +0.85% | -1.35% | |
| 41 | FDMT | 4d Molecular Therapeutics In | 股票-其他 | 0.46% | — | -5.16% | |
| 42 | ALXO | Alx Oncology Holdings Inc | 股票-其他 | 0.43% | -0.03% | -3.83% | |
| 43 | PEN | Penumbra Inc | 股票-医疗保健 | 0.43% | — | +85.91% | |
| 44 | PRME | Prime Medicine Inc | 股票-其他 | 0.42% | -0.03% | — | |
| 45 | ATRA | Atara Biotherapeutics Inc | 股票-其他 | 0.41% | +0.20% | -2.34% | |
| 46 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 0.30% | — | -4.65% | |
| 47 | STXS | Stereotaxis Inc | 股票-其他 | 0.29% | — | -14.65% | |
| 48 | ALLKGUSD | Allakos Inc | 股票-其他 | 0.25% | — | -2.04% | |
| 49 | CATBUSD | Astria Therapeutics Inc | 股票-其他 | 0.22% | — | +11.38% | |
| 50 | ACIU | AC Immune SA | 股票-其他 | 0.19% | — | -38.95% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Holding CORP | +11.2% | -13.15% | 减仓 |
| 2 | ZYME | Zymeworks Inc | +1.2% | -5.12% | 减仓 |
| 3 | REPL | Replimune Group Inc | +1.1% | +2.60% | 加仓 |
| 4 | CBLL | Ceribell Inc | +0.8% | NEW | 新建仓 |
| 5 | LIVN | LivaNova PLC | +0.7% | +19.26% | 加仓 |
| 6 | ✓ | Rapt Therapeutics Inc | +0.7% | +1183.43% | 加仓 |
| 7 | PLRX | Pliant Therapeutics Inc | +0.6% | -9.45% | 减仓 |
| 8 | ETNBGBP | 89bio Inc | +0.5% | +38.05% | 加仓 |
| 9 | ✓ | Establishment Labs Holdings In | +0.4% | +22.29% | 加仓 |
| 10 | BSX | Boston Scientific CORP | +0.3% | -5.50% | 减仓 |
| 11 | BEAM | Beam Therapeutics Inc | +0.3% | -5.12% | 减仓 |
| 12 | PEN | Penumbra Inc | +0.3% | +85.91% | 加仓 |
| 13 | ATRA | Atara Biotherapeutics Inc | +0.2% | -2.34% | 减仓 |
| 14 | PODD | Insulet CORP | +0.2% | NEW | 新建仓 |
| 15 | SLDB | Solid Biosciences Inc | +0.2% | NEW | 新建仓 |
| 16 | NUVB | Nuvation Bio Inc | +0.2% | — | 不变 |
| 17 | ALLKGUSD | Allakos Inc | +0.1% | -2.04% | 减仓 |
| 18 | ✓ | Verve Therapeutics Inc | +0.1% | -4.71% | 减仓 |
| 19 | STOK | Stoke Therapeutics Inc | +0.1% | -2.54% | 减仓 |
| 20 | SYK | Stryker CORP | +0.1% | -6.31% | 减仓 |
| 21 | AKRO | Akero Therapeutics Inc | 0% | -10.97% | 减仓 |
| 22 | STXS | Stereotaxis Inc | 0% | -14.65% | 减仓 |
| 23 | 698 | Achilles Therapeutics Pl-adr | 0% | — | 不变 |
| 24 | ALXO | Alx Oncology Holdings Inc | 0% | -3.83% | 减仓 |
| 25 | CATBUSD | Astria Therapeutics Inc | 0% | +11.38% | 加仓 |
| 26 | ANNX | Annexon Inc | 0% | -1.97% | 减仓 |
| 27 | CYTK | Cytokinetics Inc | — | -4.65% | 减仓 |
| 28 | ADAPY | Adaptimmune Therapeutics-adr | 0% | — | 不变 |
| 29 | ✓ | 0% | — | 不变 | |
| 30 | ORKA | Oruka Therapeutics Inc | 0% | — | 不变 |
| 31 | ✓ | 0% | — | 不变 | |
| 32 | PRME | Prime Medicine Inc | -0.1% | — | 不变 |
| 33 | ✓ | Lava Therapeutics NV | -0.1% | — | 不变 |
| 34 | BOLD | Boundless Bio Inc | -0.1% | -27.68% | 减仓 |
| 35 | XERS | Xeris Biopharma Holdings Inc | -0.1% | -56.90% | 减仓 |
| 36 | IMVT | Immunovant Inc | -0.1% | -10.96% | 减仓 |
| 37 | IVVD | Invivyd Inc | -0.1% | -1.74% | 减仓 |
| 38 | ARDX | Ardelyx Inc | -0.1% | -5.09% | 减仓 |
| 39 | CABA | Cabaletta Bio Inc | -0.1% | EXIT | 清仓 |
| 40 | ISRG | Intuitive Surgical Inc | -0.2% | -36.54% | 减仓 |
| 41 | IDYA | Ideaya Biosciences Inc | -0.2% | -9.08% | 减仓 |
| 42 | NRIX | Nurix Therapeutics Inc | -0.2% | -2.06% | 减仓 |
| 43 | 2JQ | Gritstone Bio Inc | -0.2% | EXIT | 清仓 |
| 44 | ACIU | AC Immune SA | -0.2% | -38.95% | 减仓 |
| 45 | RPTX | Repare Therapeutics Inc | -0.2% | -1.36% | 减仓 |
| 46 | CLDX | Celldex Therapeutics Inc | -0.2% | -6.30% | 减仓 |
| 47 | VTYXUSD | Ventyx Biosciences Inc | -0.3% | -94.11% | 减仓 |
| 48 | NGNE | Neurogene Inc | -0.3% | +36.86% | 加仓 |
| 49 | FDMT | 4d Molecular Therapeutics In | -0.3% | -5.16% | 减仓 |
| 50 | ABSI | Absci CORP | -0.4% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案，Redmile Group, LLC 在 Q4 2024 季度的美股持仓总市值约为 US$14.9亿，共申报了 62 个公开持股仓位。
在 Q4 2024 季度，Redmile Group, LLC 按市值排列的前三大核心持股分别为：SRRK (13.7%)、KRYS (8.2%)、NRIX (5.5%)。其中最大持股仓位 SRRK 占据整体投资组合约 13.7% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CBLL
市值: US$1126.4万
本季最大获利了结 / 清仓标的
AUGX
前期市值: US$3849.4万
在 Q4 2024 季度中，Redmile Group, LLC 共进行了 56 项持仓异动，包含新建仓 3 个仓位、加仓 9 个仓位、减仓 40 个仓位以及清仓 4 个仓位。 其中最大新建仓标的为 CBLL。 本季清仓仓位包含 AUGX。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。